RAPT THERAPEUTICS INC (RAPT) Stock Income Statement
NASDAQ:RAPT - Nasdaq - US75382E1091 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 1.53M | 3.81M | |||
| Operating Expenses | 122.00M | 136.00M | 127.00M | 87.32M | 73.02M | |||
| Research and Development | N/A | N/A | 101.00M | 67.08M | 56.99M | |||
| Selling, General, and Administrative Expenses | 28.37M | 29.00M | 26.00M | 20.24M | 16.04M | |||
| Operating Income | -122.00M | -136.00M | -127.00M | -85.80M | -69.21M | |||
| Other Income/Expense | 6.35M | 6.24M | 10.00M | 1.96M | 10.00K | |||
| Income Before Taxes | -116.00M | -130.00M | -117.00M | -83.84M | -69.20M | |||
| Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
| Net Income | -116.00M | -130.00M | -117.00M | -83.84M | -69.20M | |||
| EBITDA | -120.86M | -134.80M | -125.78M | -84.75M | -68.21M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.40 | -3.19 | -3.07 | -2.58 | -2.53 | |||
| Non GAAP EPS | -2.40 | -3.11 | -3.04 | -2.58 | -2.53 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | -5479.74% | -1816.27% | |||
| Operating Profit Margin | N/A | N/A | N/A | -5607.84% | -1816.54% | |||
All data in USD